Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Janet Pope, MD, FRCPC, MPH

University of Western Ontario
London, ON, Canada

Professor of Medicine at University of Western Ontario, Division Head, Rheumatology at St. Joseph's Health Care, London, Ontario.

Presentation(s):

  • 13M123: Plenary II (1579–1584)

    Monday, November 13, 2023
    11:00 AM – 12:30 PM PT

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer Ingelheim: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); Frensenius Kabi: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Janssen: Consultant (Ongoing); Mallinckrodt: Consultant (Ongoing); Novartis: Consultant (Ongoing); Organon: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Sandoz: Consultant (Ongoing); Viatris: Consultant (Ongoing)

  • 15W103: Late-Breaking Abstracts (L15–L20)

    Wednesday, November 15, 2023
    7:30 AM – 9:00 AM PT

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer Ingelheim: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); Frensenius Kabi: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Janssen: Consultant (Ongoing); Mallinckrodt: Consultant (Ongoing); Novartis: Consultant (Ongoing); Organon: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Sandoz: Consultant (Ongoing); Viatris: Consultant (Ongoing)

  • 15W119: Clinical Year in Preview

    Wednesday, November 15, 2023
    10:30 AM – 11:30 AM PT

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer Ingelheim: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); Frensenius Kabi: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Janssen: Consultant (Ongoing); Mallinckrodt: Consultant (Ongoing); Novartis: Consultant (Ongoing); Organon: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Sandoz: Consultant (Ongoing); Viatris: Consultant (Ongoing)